Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States
Open Forum Infectious Diseases · 03.05.2023 · 10 (5)
DOI: 10.1093/ofid/ofad203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 13.04.2023. Verfasst von Jessica K DeMartino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Janssen Scientific Affairs, LLC.
Abstract (Originalsprache)
Background
Literature describing respiratory syncytial virus (RSV)–related complications in older adults in the United States is scarce. This study described risk factors of RSV-related complications and healthcare costs of Medicare-insured patients aged ≥60 years with medically attended RSV.
Methods
100% Medicare Research Identifiable Files (1 January 2007–31 December 2019) were used to identify adults aged ≥60 years with RSV (index: first diagnosis date). Predictors of ≥1 RSV-related complication (ie, pneumonia, acute respiratory failure, congestive heart failure, hypoxia/dyspnea, non-RSV lower/upper respiratory tract infections, or chronic respiratory disease) during the up to 6-month post–RSV diagnosis period were identified. Patients with all aforementioned diagnoses during the 6 months pre-index could not be evaluated for a complication and were therefore ineligible for analyses. Differences between 6-month pre- and post-index total all-cause and respiratory/infection-related healthcare costs were assessed.
Results
Overall, 175 392 patients with RSV were identified. Post–RSV diagnosis, 47.9% had ≥1 RSV-related complication, with mean time-to-event of 1.0 month. The most common complications were pneumonia (24.0%), chronic respiratory disease (23.6%), and hypoxia or dyspnea (22.0%). Baseline predictors of ≥1 RSV-related complication included having previous diagnoses for complication/comorbidity listed in the Methods, hypoxemia, chemotherapy, chest radiograph, stem cell transplant, and anti-asthmatic and bronchodilator use. Total all-cause and respiratory/infection-related healthcare costs were $7797 and $8863 higher, respectively, post-index versus pre-index (both P < .001).
Conclusions
In this real-world study, almost half of patients with medically attended RSV experienced an RSV-related complication within 1 month post–RSV diagnosis, and costs significantly increased post-diagnosis. Having a complication/comorbidity pre-RSV predicted a higher risk of developing a different complication post–RSV infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
- Analysis Group, Inc, Montreal, Quebec, Canada.
- Analysis Group, Inc, Menlo Park, California, USA.
Förderung
- Janssen Scientific Affairs, LLC
Zitieren
APA
DeMartino, J. K., Lafeuille, M. H., Emond, B., Rossi, C., Wang, J., Liu, S., Lefebvre, P., & Krishnarajah, G. (2023). Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States. Open Forum Infectious Diseases, 10(5). https://doi.org/10.1093/ofid/ofad203
Vancouver
DeMartino JK, Lafeuille MH, Emond B, Rossi C, Wang J, Liu S, et al. Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States. Open Forum Infectious Diseases. 2023;10(5). doi:10.1093/ofid/ofad203
BibTeX
@article{DeMartino2023,
author = {DeMartino, Jessica K and Lafeuille, Marie-Hélène and Emond, Bruno and Rossi, Carmine and Wang, Jingru and Liu, Stephanie and Lefebvre, Patrick and Krishnarajah, Girishanthy},
title = {Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States},
journal = {Open Forum Infectious Diseases},
year = {2023},
volume = {10},
number = {5},
doi = {10.1093/ofid/ofad203}
}
EUVIMED